Miso Clinic · Clinical column

Skin Boosters in Your 40s · 50s — Before Age, What Has Decreased

“I'm in my 50s — which booster should I have?” I'm often asked this, but age alone doesn't give an answer. Even at the same age, skin and fat layer thickness vary greatly from person to person, and in the 40s · 50s texture roughening, thinning, hollowing and sagging often start all at once. This article divides the concerns that tend to overlap at this age by layer and sets out which a booster can handle and which it can't.

Clinical column About 6 min October 2026 Miso Clinic, Daegu · Dr. Lee Chi-Hak, Medical Director

The short answer

Skin boosters in your 40s · 50s aren't about choosing a product by age, but about dividing the thinning · dryness · texture · hollowing · sagging that tend to overlap at this age by layer and using boosters only for dermal problems. The mean age of booster study participants is already in this range (Byryzn 54.1, hADM split-face trial 54.7, CaHA review 50.2), but I couldn't confirm any study reporting results separately by age group. Facial skin and superficial fat thickness also vary greatly (skin 2.1 ± 0.4 mm, superficial fat 5.2 ± 1.9 mm), so the criterion is what has decreased now rather than age. Miso Clinic in Daegu (4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, +82-53-428-2700) doesn't simply repeat boosters when sagging is also present but plans an order with radiofrequency lifting (clinical judgement).

What overlaps in skin in your 40s · 50s?

Concerns that come up together in consultation at this age are usually five. These are problems in different layers, so the right treatment differs too.

Concerns and layers that tend to overlap in the 40s · 50s
ConcernWhich layer's problemDoes a booster handle it?
Texture is rough and makeup liftsDermis · surfaceYes
Skin has thinned and lacks firmnessDermisYes
It's dry and tightDermis · barrierPartly — barrier care is needed too
Cheeks · temples have hollowedFat · volumeNo — that's a job for filling materials
My jawline is blurring and my cheeks have droppedStructures below the dermisNo — that's a job for lifting devices

This table explains why some people have had only boosters but their jawline is unchanged, and others have had only devices but makeup still lifts. It's normal to fall under several rows, and then what to do isn't “do it all” but pick the one row that bothers you first.

Why can't the product be chosen by age?

Even at the same age, facial layer thickness varies a lot. In a study measuring 30 cadavers in 3D, skin was 2.1 ± 0.4 mm and superficial fat 5.2 ± 1.9 mm, with large individual variation (Lee 2021). In a study looking at the lower face of 200 people with ultrasound, sagging areas had thinner skin and thicker superficial fat (Kwon 2022). In other words, there's no single state called “50s skin.”

The research side is the same. The mean age of booster study participants is usually late 40s to 50s, but I couldn't confirm any booster study reporting results separately by age group. So a formula like “A in your 40s, B in your 50s” isn't backed by data.

How old were the study participants?

To help when considering “does this study apply to my age,” I've gathered the ages of participants in the data cited in this article.

Ages of participants in booster-related studies
DataSubjectsDesign
Byryzn (cross-linked HA)20 people, mean age 54.1Prospective single-arm pilot, 3 sessions 2 weeks apart · 12 weeks, no control group
hADM split-face trial (Rituo line)20 people, mean age 54.7Split-face double-blind randomized, 20 weeks, hyaluronic acid on the other side
Review of controlled CaHA studies13 studies · 1,171 people, mean age 50.2, 93.3% womenSystematic review; risk of bias noted
Suspension-type PCL biopsy13 people, mean age 38.7Opposite temple as control; dermal thickness +26.7% at 1 year
Hyaluronic acid biopsy11 people, mean age 74Saline control; type I · III procollagen increased

As you can see, participant ages range from the late 30s to the 70s. In particular, the PCL biopsy had a mean age of 38.7, so it's hard to carry those figures straight over to skin in the 50s. Human data on liquid PCL (Gouri) are still at case-report scale.

What else do you look at around menopause?

The average age of natural menopause in Korean women is reported at about 49–50 (Choi 2015 · Park 2002). This period overlaps with 40s · 50s consultations. However, I couldn't confirm any study comparing skin booster response before and after menopause.

So Miso Clinic doesn't change products based on menopause status, but asks separately at consultation about dryness · increased sensitivity · recently changed skin reactions (clinical judgement). If the barrier has broken down and the skin stings and is red, recovery comes before boosters — see What happens when the skin barrier breaks down and Treatment planning for thin, dry skin together.

What do you look at first by concern?

Choosing by main concern instead of age looks like this.

40s · 50s concern → what we look at first (clinical judgement)
Main concernWhat we look at firstReasons and cautions
Thinned and lacking firmnessRituo · CellREDM (hADM)Directly adds the dermal material that has decreased. There's no large-scale data on the products themselves yet
Texture and density across the whole faceGouriA formulation that spreads across a surface. Irreversible, so we start conservatively
Texture · fine lines, sensitive skinRejuranWorks on the environment without volume. Planned as a course of 3–4 sessions 3–4 weeks apart
Dryness · tightnessHyaluronic acid boosterReversible
Loss of elasticity + gradual hollowing of cheeks · templesRadiesse (CaHA)Immediate volume together with collagen stimulation. No dissolving agent
Sagging jawlineRadiofrequency lifting (Density · XERF)Not a booster's job

Skin that suits each product is written separately in Skin that suits Rituo · Skin that suits Gouri · Skin that suits Rejuran.

What if sagging is also present?

In the 40s · 50s, texture · thickness problems often come with a sagging jawline. Then if you only repeat boosters, texture improves but the contour stays the same. When both problems are present, Miso Clinic generally chooses the order of radiofrequency lifting first, then a booster 2–4 weeks later (clinical judgement).

That said, there's no evidence that doing them together is better than each alone — in two split-face randomized trials, adding a device to filler made no difference. The reason for doing two things isn't synergy but that there are two problems to address. Order, intervals and whether the same day is possible are set out in Combining skin boosters. Lifting by age group is in Lifting by age group.

How are sessions and the start set?

  1. ConsultationSettle on one thing that has decreasedPut into words the one thing that bothers you first among texture · thickness · volume · sagging.
  2. First treatmentStart with room to reverseIf it's your first time, we mention reversible hyaluronic acid or PN, which breaks down, first. With irreversible materials we start on the low side.
  3. 4 weeks laterCheck and decide whether to addFor irreversible materials such as Gouri, this is when we decide whether to add more. Rejuran continues as a course 3–4 weeks apart.
  4. After thatOn to the next concernAfter seeing how the first concern progresses, we decide whether to address problems in another layer. We don't layer several boosters on the same day.

The intervals above aren't numbers set by research but Miso Clinic's planning (clinical judgement). For most lines I couldn't confirm trials comparing sessions and duration against other frequencies. See How many sessions, and how long it lasts too.

Skin boosters in your 40s · 50s: frequently asked questions

Is there a skin booster specifically for your 50s?

I couldn't confirm any booster study reporting results separately by age group. Even among people in their 50s, skin and fat layer thickness vary greatly, so we choose by what has decreased now (texture · thickness · volume) rather than age.

If I'm having a skin booster for the first time in my 40s, what's a safe choice?

We mention reversible hyaluronic acid boosters or Rejuran (PN), which breaks down, first. It's not too late to look at irreversible materials once the direction is clear.

Do skin boosters lift a sagging jawline too?

Boosters work on the material of the dermis, so they can't lift a descended contour. A sagging jawline is the domain of radiofrequency lifting such as Density · XERF, and if both problems are present we plan them together in a set order.

Should boosters be done differently after menopause?

I couldn't confirm any study comparing booster response before and after menopause. Miso Clinic doesn't change products by menopause status; we look separately at dryness and increased sensitivity, and if the barrier has broken down we restore it first.

Will having several boosters together improve things faster?

If layered on the same day, you can't tell which caused a reaction, so we space them out. We put one in first, check the condition after 4 weeks, then decide the combination.

Where can I get a skin booster consultation for my 40s · 50s in Daegu?

Miso Clinic in Daegu is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital Station. +82-53-428-2700; weekdays 11:00–19:00 · Saturday 10:00–16:00 (no lunch break); closed Sundays · public holidays.

Clinical columns to read next

Product reference

Related notes: Rituo · CellREDM · Gouri · Rejuran · Radiesse

Clinic

This column was written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu. The treatment criteria and injection design are written exactly as we actually use them.

Miso Clinic
Medical DirectorLee Chi-Hak, MD
Address4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu (Exit 1, Kyungpook National University Hospital Station) · tower parking in the building
Phone053-428-2700
KakaoTalk consultationMiso Clinic Daegu channel
KakaoTalk channelAdd the channel
Opening hoursWeekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays
Clinical columnSee all columns
Reference libraryAll booster and lifting device references

References

  1. Individual variation in facial layer thickness — Lee KW et al., Clinical Anatomy 2021;34(7):1050–1058, PMID 33583088. 3D measurement of 30 fixed cadavers; skin 2.1 ± 0.4 mm, superficial fat 5.2 ± 1.9 mm.
  2. Ultrasound of lower-face layer structure — Kwon SH et al., Dermatologic Surgery 2022;48(5):527–531, PMID 35093961. Retrospective review of 200 people. Sagging submental areas had thinner skin and thicker superficial fat.
  3. Gaps in age-group data — ultrasound lifting clinical studies have a mean age of 44–52; none of three large reviews (Amiri 2025 · Haykal 2025 · Modena 2025) reported results by age. Average age of natural menopause in Korean women about 49–50 (Choi B-O et al., Korean J Fam Med 2015; Park YJ et al., 2002).
  4. Byryzn human study — Lee JH et al., J Cosmet Dermatol 2024;23(2):409–416, DOI 10.1111/jocd.15944. Prospective · single-centre · single-arm pilot, 20 people (mean age 54.1), 3 intradermal injections 2 weeks apart, observed 12 weeks. Lemperle wrinkle scale 2.60 ± 0.60 → 1.55 ± 0.51 at 8 weeks (about 40% reduction), held at about 33% at 12 weeks. Transient subcutaneous nodule in 1 person. No control group.
  5. Re2O split-face trial — Yonsei University Severance Hospital, split-face double-blind randomised trial (NCT07155278), International Journal of Molecular Sciences 2026. 20 people · 20 weeks · Re2O on one side, hyaluronic acid on the other. Exploratory in scale.
  6. Systematic review of CaHA — Journal of Clinical Medicine 2024. 13 controlled studies · 1,171 people; noted risk of bias in design and differences between studies made pooled analysis difficult.
  7. Human data on liquid PCL — 2 Australian case reports (women aged 28 · 32, 2 sessions 4 weeks apart, 12-week follow-up, mean patient rating 4.0 · practitioner rating 3.0). The dermal-thickness biopsy (Kim JS, Aesthetic Surgery Journal 2019;39(12):NP484, 13 people · mean age 38.7, opposite temple as control) was done with a suspension-type PCL containing microspheres, so it isn't carried straight over to the liquid type (Gouri).
  8. Dermal thickness and pores are different variables — in human biopsy of microsphere PCL, dermal thickness +26.7% ± 9.3% at 1 year (13 people, P < 0.001). This is dermal thickness data, not data measuring pores as the primary variable.
  9. Hyaluronic acid and collagen — Wang F, Fisher GJ, Voorhees JJ et al., Archives of Dermatology 2007;143(2):155. Biopsies at 4 · 13 weeks after cross-linked hyaluronic acid injection into photoaged skin (11 people, mean age 74, saline control). Increased type I · III procollagen expression (P<.05).
  10. Rejuran HB PLUS — made by Pharma Research, PN + hyaluronic acid + lidocaine, Korean medical device. The course of 3–4 sessions 3–4 weeks apart is Miso Clinic’s recommended design.
  11. Randomized trial where combining wasn't better than each alone ① — Goldman MP et al., Dermatol Surg 2007;33(5):535–542. 36 people, split-face · nasolabial folds, filler alone vs filler + non-ablative laser · monopolar radiofrequency · IPL. No significant difference in wrinkle severity or global assessment (per abstract).
  12. Randomized trial where combining wasn't better than each alone ② — Park et al., Dermatol Surg 2011;37(12):1770–1775. 12 Korean people, split-face; combining a non-ablative infrared device with hyaluronic acid filler didn't increase efficacy (per abstract).
  13. Korean medical advertising law — Medical Service Act Article 56(2), which prohibits testimonial advertising, comparison with other medical institutions and superlative claims.
  14. Miso Clinic clinical guidelines — criteria for indications, design by area, pre-treatment explanation and consent. The source of sentences marked “clinical judgement” in this column.

Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.

← Clinical columns · Reference library · Miso Clinic home

한국어 · English · 日本語